Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

The dichotomy of inhibiting nuclear factor kappa-B in pneumonia.

Abraham E.

Crit Care. 2013 Jun 11;17(3):152. doi: 10.1186/cc12722.

2.

Inhibition of pulmonary nuclear factor kappa-B decreases the severity of acute Escherichia coli pneumonia but worsens prolonged pneumonia.

Devaney J, Curley GF, Hayes M, Masterson C, Ansari B, O'Brien T, O'Toole D, Laffey JG.

Crit Care. 2013 Apr 27;17(2):R82. doi: 10.1186/cc12696.

5.

Effects of acetaldehyde and TNF alpha on the inhibitory kappa B-alpha protein and nuclear factor kappa B activation in hepatic stellate cells.

Novitskiy G, Ravi R, Potter JJ, Rennie-Tankersley L, Wang L, Mezey E.

Alcohol Alcohol. 2005 Mar-Apr;40(2):96-101. Epub 2004 Nov 18.

PMID:
15550448
6.

NF-kappaB regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome.

Moine P, McIntyre R, Schwartz MD, Kaneko D, Shenkar R, Le Tulzo Y, Moore EE, Abraham E.

Shock. 2000 Feb;13(2):85-91.

PMID:
10670837
7.

NF-kappa B regulation in human neutrophils by nuclear I kappa B alpha: correlation to apoptosis.

Castro-Alcaraz S, Miskolci V, Kalasapudi B, Davidson D, Vancurova I.

J Immunol. 2002 Oct 1;169(7):3947-53.

8.

Cardiac-specific abrogation of NF- kappa B activation in mice by transdominant expression of a mutant I kappa B alpha.

Dawn B, Xuan YT, Marian M, Flaherty MP, Murphree SS, Smith TL, Bolli R, Jones WK.

J Mol Cell Cardiol. 2001 Jan;33(1):161-73.

PMID:
11133232
9.

Inhibition of nuclear factor-κB in the lungs prevents monocrotaline-induced pulmonary hypertension in mice.

Li L, Wei C, Kim IK, Janssen-Heininger Y, Gupta S.

Hypertension. 2014 Jun;63(6):1260-9. doi: 10.1161/HYPERTENSIONAHA.114.03220. Epub 2014 Mar 10.

10.

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Karin M, Ben-Neriah Y.

Annu Rev Immunol. 2000;18:621-63. Review.

PMID:
10837071
11.

Systemic blood loss affects NF-kappa B regulatory mechanisms in the lungs.

Moine P, Shenkar R, Kaneko D, Le Tulzo Y, Abraham E.

Am J Physiol. 1997 Jul;273(1 Pt 1):L185-92.

PMID:
9252555
14.

Hypoxic suppression of E. coli-induced NF-kappa B and AP-1 transactivation by oxyradical signaling.

Matuschak GM, Lechner AJ, Chen Z, Todi S, Doyle TM, Loftis LL.

Am J Physiol Regul Integr Comp Physiol. 2004 Aug;287(2):R437-45. Epub 2004 Apr 1.

15.

Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis.

Sethi G, Ahn KS, Aggarwal BB.

Mol Cancer Res. 2008 Jun;6(6):1059-70. doi: 10.1158/1541-7786.MCR-07-2088.

17.

Superoxide potentiates NF-kappaB activation and modulates endotoxin-induced cytokine production in alveolar macrophages.

Ndengele MM, Muscoli C, Wang ZQ, Doyle TM, Matuschak GM, Salvemini D.

Shock. 2005 Feb;23(2):186-93.

PMID:
15665736
18.

Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B.

Arenzana-Seisdedos F, Thompson J, Rodriguez MS, Bachelerie F, Thomas D, Hay RT.

Mol Cell Biol. 1995 May;15(5):2689-96.

19.

Nuclear factor-kappaB p50 limits inflammation and prevents lung injury during Escherichia coli pneumonia.

Mizgerd JP, Lupa MM, Kogan MS, Warren HB, Kobzik L, Topulos GP.

Am J Respir Crit Care Med. 2003 Oct 1;168(7):810-7. Epub 2003 Jul 11.

PMID:
12857723
20.

Supplemental Content

Support Center